StockIQ.techMedtronic plc (MDT) Stock Analysis
Free AI-powered analysis and research for Medtronic plc stock
Sector: Healthcare
MDT snapshot
Data as of 3 Nov 2026 close. Updated daily.
Medtronic plc scores 91/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 78% of its 52-week range, up 9.7% over the past year. Latest reported figures show a profit margin of 13.9%, return on equity of 10.6% and revenue growth of +13.7%.
What is driving the score
- Strong Uptrend: +12
- MACD Bullish: +8
- Good Profit Margin (13.9%): +5
- Strong Liquidity (2.07 Current Ratio): +8
- Strong Long-term Uptrend: +8
- Up Over 1 Year (+9.7%): +3
- Low Volume (0.1x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full MDT report
Medtronic plc (MDT) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze MDT Now →📰 Latest Update
Biosensors - Global Strategic Business Report: Secure Share of the $53.7 Billion Market by 2030 as Abbott, Dexcom, Medtronic and Masimo Accelerate Wearable and AI Diagnostics
Tue, November 3, 2026 at 2:41 PM UTC 3 min read
The global biosensors market, valued at US$35.3 billion in 2024, is projected to reach US$53.7 billion by 2030, growing at a CAGR of 7.2%. Key drivers include the demand for chronic disease monitoring, personalized medicine, and advancements in nanotechnology and portable diagnostics. The report highlights the increasing importance of wearable biosensors, which are expected to grow at a faster CAGR of 7.9%, and examines the impact of regulatory changes and technological innovations on the industry.